Nova Patents
PL3019167T3

Treating elevated levels of eosinophils and/or basophils

Abstract

This record has no abstract on file.

Term

7.8 yearsto projected expiry

Projected expiry 11 July 2034, counted from filing; an application has no term until it is granted.

  1. Priority
  2. Filed
  3. Published
  4. Today
  5. Projected expiry

97 members in 21 offices

This recordMember, by publication datePriority claim11 more offices are in the list below

Priority claims7

Priority claims
DocumentOfficeKindDate
201361845944United States of AmericaP
201361859158United States of AmericaP
201361865118United States of AmericaP
201313966229United States of AmericaA
2013054804United States of AmericaW
201461987117United States of AmericaP
2014046380United States of AmericaW

Members97

Family members, oldest first
DocumentOfficeKind
CA2918035A1CanadaA1
US2015018397A1United States of AmericaA1
WO2015006708A1World Intellectual Property Organization (WIPO)A1
CA2921378A1CanadaA1
CA2921381A1CanadaA1
WO2015023786A1World Intellectual Property Organization (WIPO)A1
WO2015023790A1World Intellectual Property Organization (WIPO)A1
AU2014287067A1AustraliaA1
AU2014306597A1AustraliaA1
AU2014306683A1AustraliaA1
IL244118D0IsraelD0
IL244119D0IsraelD0
EP3019167A1European Patent Office (EPO)A1
US2016158205A1United States of AmericaA1
EP3033081A1European Patent Office (EPO)A1
EP3038467A1European Patent Office (EPO)A1
US2016193186A1United States of AmericaA1
US2016193187A1United States of AmericaA1
CN105764507AChinaA
JP2016523981AJapanA
US9468630B2United States of AmericaB2
US2016354350A1United States of AmericaA1
EP3019167A4European Patent Office (EPO)A4
EP3038467A4European Patent Office (EPO)A4
US9642840B2United States of AmericaB2
EP3033081A4European Patent Office (EPO)A4
BR112016000627A2BrazilA2
US9763918B2United States of AmericaB2
US2017281604A1United States of AmericaA1
AU2014306683B2AustraliaB2
AU2017276231A1AustraliaA1
US2018015073A1United States of AmericaA1
AU2014306597B2AustraliaB2
JP6329717B2JapanB2
US10028940B2United States of AmericaB2
US2018228777A1United States of AmericaA1
US2018271839A1United States of AmericaA1
US2019022070A1United States of AmericaA1
US10195183B2United States of AmericaB2
IL243508AIsraelA
IL243508BIsraelB
AU2014287067B2AustraliaB2
AU2017276231B2AustraliaB2
CN105764507BChinaB
AU2014287067C1AustraliaC1
IL244119AIsraelA
IL244119BIsraelB
US10383856B2United States of AmericaB2
US10383857B2United States of AmericaB2
US2019321339A1United States of AmericaA1
US10456381B2United States of AmericaB2
IL244118AIsraelA
IL244118BIsraelB
EP3038467B1European Patent Office (EPO)B1
US10828284B2United States of AmericaB2
EP3019167B1European Patent Office (EPO)B1
PT3019167TPortugalT
DK3019167T3DenmarkT3
ES2813674T3SpainT3
LT3019167TLithuaniaT
HRP20210368T1CroatiaT1
US10980783B2United States of AmericaB2
RS61539B1SerbiaB1
SI3019167T1SloveniaT1
SMT202100119T1San MarinoT1
EP3033081B1European Patent Office (EPO)B1
DK3033081T3DenmarkT3
PT3033081TPortugalT
US11026928B2United States of AmericaB2
PL3019167T3This recordPolandT3
EP3838271A1European Patent Office (EPO)A1
HUE054185T2HungaryT2
PL3033081T3PolandT3
US2021267949A1United States of AmericaA1
ES2858500T3SpainT3
ES2871556T3SpainT3
HUE055850T2HungaryT2
BR112016000627B1BrazilB1
CY1123914T1CyprusT1
CA2918035CCanadaC
US11612589B2United States of AmericaB2
US2023277509A1United States of AmericaA1
US12138249B2United States of AmericaB2
US2025099437A1United States of AmericaA1
EP4578509A2European Patent Office (EPO)A2
EP3838271B1European Patent Office (EPO)B1
PT3838271TPortugalT
DK3838271T3DenmarkT3
FI3838271T3FinlandT3
RS67279B1SerbiaB1
LT3838271TLithuaniaT
SMT202500364T1San MarinoT1
EP4578509A3European Patent Office (EPO)A3
HRP20251187T1CroatiaT1
ES3043076T3SpainT3
PL3838271T3PolandT3
SI3838271T1SloveniaT1